VTP-201227
VTP-201227 Uses, Dosage, Side Effects, Food Interaction and all others data.
VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications. It is being developed by Vitae Pharmaceuticals.
VTP-201227 is a potent, selective inhibitor of two specific enzymes that are active in the skin. Therapeutic targeting of these enzymes by VTP-201227 promotes naturally-occurring healing processes within the skin. The compound has been designed to be rapidly inactivated in systemic circulation and thus has the potential to have a more favorable safety profile. In preclinical animal models, VTP-201227 was shown to exhibit a superior therapeutic index compared to other topical dermatology drugs.
| Trade Name | VTP-201227 |
| Generic | VTP-201227 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in psoriasis and psoriatic disorders.
Innovators Monograph
You find simplified version here VTP-201227
